Adding Insult to Injury: Paying for Harms Caused by a Competitor’s Copycat Product

Tort Trial and Insurance Practice Law Journal, Vol. 45, p. 673, 2010

Posted: 11 Sep 2010 Last revised: 21 Sep 2015

See all articles by Lars Noah

Lars Noah

University of Florida Levin College of Law

Date Written: February 15, 2010

Abstract

Even though generic drugs now account for more than two-thirds of dispensed prescriptions, to date they have played almost no discernible role in products liability litigation. In the last few years, however, courts have begun to confront challenging questions presented when plaintiffs assert tort claims for injuries caused by the use of generic drugs, including negligent misrepresentation claims brought against the manufacturers of the brand-name versions of those products even though never used by the patient. Such cross-over litigation uniformly failed until a couple of years ago when the California courts allowed a plaintiff to maintain claims against only the brand-name drug manufacturer even though she had ingested only the generic version. This article explains the profound though not entirely self-evident illogic of such an approach.

Suggested Citation

Noah, Lars, Adding Insult to Injury: Paying for Harms Caused by a Competitor’s Copycat Product (February 15, 2010). Tort Trial and Insurance Practice Law Journal, Vol. 45, p. 673, 2010 , Available at SSRN: https://ssrn.com/abstract=1674662

Lars Noah (Contact Author)

University of Florida Levin College of Law ( email )

P.O. Box 117625
Gainesville, FL 32611-7625
United States
352-273-0923 (Phone)
352-392-3005 (Fax)

HOME PAGE: http://www.law.ufl.edu/faculty/lars-noah

Do you have negative results from your research you’d like to share?

Paper statistics

Abstract Views
601
PlumX Metrics